Skip to main content
Helixmith Co., Ltd logo

Helixmith Co., Ltd — Investor Relations & Filings

Ticker · 084990 ISIN · KR7084990001 KO Manufacturing
Open in API
Filings indexed 508 across all filing types
Latest filing 2020-05-06 Director's Dealing
Country KR South Korea
Listing KO 084990

About Helixmith Co., Ltd

https://www.helixmith.com/

Helixmith is a biotechnology company specializing in the research and development of gene therapies. Established in 1996, the company focuses on creating innovative biopharmaceuticals for diseases with significant unmet medical needs. Its core activities revolve around an extensive pipeline of next-generation gene therapy products. The primary therapeutic areas of focus include neurological and cardiovascular disorders, such as peripheral artery disease and coronary artery disease. Helixmith manages a comprehensive range of capabilities, from discovery and preclinical studies to clinical development of its drug candidates.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service (South Korea). It details the share ownership and changes in holdings (specifically, the acquisition of bonus shares) by an executive (CFO) of Helixmith. This type of filing is a standard regulatory disclosure for insider share transactions, which falls under the 'Director's Dealing' category.
2020-05-06 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (DART system) used by corporate insiders (directors/executives) to disclose their shareholdings and changes therein. This corresponds to the 'Director's Dealing' category, which covers insider trades and changes in ownership by company directors and executives.
2020-05-06 Korean
전환가액의조정(제2회차)
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing from Helixmith regarding the adjustment of the conversion price for its 2nd series convertible bonds due to a bonus issue (free capital increase). This type of disclosure, which details changes to the capital structure and conversion terms of financial instruments, falls under the category of capital and financing updates.
2020-04-23 Korean
전환가액의조정(제3회차)
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing from Helixmith regarding the adjustment of the conversion price for its 3rd series convertible bonds due to a bonus issue (free capital increase). This type of disclosure, which details changes to the terms of existing financial instruments (specifically conversion prices), falls under capital structure and financing updates. In the provided taxonomy, 'CAP' (Capital/Financing Update) is the most accurate category for adjustments to convertible bond terms.
2020-04-23 Korean
투자판단관련주요경영사항(샤르코-마리-투스병 치료제(Engensis: VM202) 제1/2a상 임상시험계획 승인)
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from Helixmith regarding the approval of a Phase 1/2a clinical trial for their drug candidate (Engensis: VM202) by the Ministry of Food and Drug Safety (MFDS). It details the clinical trial objectives, methodology, and potential risks. Since it is a specific regulatory announcement regarding clinical trial status and does not fit into the other specialized categories like financial reports or shareholder meetings, it is classified as a Regulatory Filing (RNS).
2020-04-21 Korean
권리락(무상증자)
Share Issue/Capital Change Classification · 95% confidence The document is a short announcement regarding a 'rights off' (권리락) event due to a bonus issue (무상증자) for the company Helixmith. It provides specific details such as the reference price and the effective date. This type of corporate action announcement regarding capital changes fits the definition of a share issue or capital change announcement.
2020-04-21 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.